Patents by Inventor Julian EGGER

Julian EGGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210314142
    Abstract: A Computer-implemented method is provided for encrypting data by a server in cooperation with a predetermined number of rate limiters. The method includes receiving, by the server, a user identification, and a password to be encrypted and creating a secret message, the secret message being a key suitable for use with a symmetric key encryption/decryption scheme. The method further includes generating, on the basis of a predetermined interactive cryptographic encryption protocol, a ciphertext which encrypts the user password, and the secret message using secret keys of the rate limiters of the subset, where the threshold is smaller than or equal to the number of rate limiters, and the protocol is adapted such that the server needs only to interact with a subset of the predetermined size of the number of rate limiters for decryption of the ciphertext to recover the secret message.
    Type: Application
    Filed: March 30, 2021
    Publication date: October 7, 2021
    Inventors: Russell W. F. Lai, Dominique Schröder, Christoph Egger, Julian Brost
  • Patent number: 11053518
    Abstract: What is described herein relates to a method of selectively hydrolyzing an enantiomer of an alpha haloalkanoic acid according to formula I employing a polypeptide having dehalogenase activity comprising an amino acid sequence as set forth in SEQ ID NO. 1 or SEQ ID NO. 4 or a sequence with at least 80% sequence identity to either of said sequences and to the use of said method.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: July 6, 2021
    Assignee: Bayer Aktiengesellschaft
    Inventors: Markus Spelberg, Julian Egger
  • Publication number: 20210017152
    Abstract: The present invention relates to a process for preparing 4-{[(2S)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl]amino}-2-fluorobenzamide (I) or 4-({(2S)-2-[4-{5-chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (II) from 2,5-dimethoxypyridine (III), 1-(2-bromo-4-chlorophenyl)-4-chloro-1H-1,2,3-triazole (X-Cl) or 1-(2-bromo-4-chlorophenyl)-4-(trifluoromethyl)-1H-1,2,3-triazole (X-CF3), 4-amino-2-fluorbenzamide (XIII) and (2R)-2-aminobutanoic acid (XVII).
    Type: Application
    Filed: March 8, 2019
    Publication date: January 21, 2021
    Inventors: Julian EGGER, Daniel GOETZ, Michal SOWA
  • Publication number: 20200277633
    Abstract: What is described herein relates to a method of selectively hydrolyzing an enantiomer of an alpha haloalkanoic acid according to formula I employing a polypeptide having dehalogenase activity comprising an amino acid sequence as set forth in SEQ ID NO. 1 or SEQ ID NO. 4 or a sequence with at least 80% sequence identity to either of said sequences and to the use of said method.
    Type: Application
    Filed: September 24, 2018
    Publication date: September 3, 2020
    Inventors: Markus SPELBERG, Julian EGGER